PatientDirected

PatientDirected

Patient Directed Healthcare Data Market

Print
Security Type
Non-Voting Equity
Min Investment
$399
Location
Newport Beach, CA
Offering Date
July 30, 2018
Expected Close Date
October 30, 2018
Target Raise
$10.00K-$107.00K
Deal Notes
  • Non-Voting Common Stock designated as "PDEQ Tokens" and PTDIR Tokens
  • $1.50/share of Non-Voting Common Stock designated as "PDEQ Tokens
  • Minimum Investment Amount (per investor): $399.00
Valuation
$7,600,000

Company Description

Imagine a world where precious healthcare data is liberated from the many private data silos and placed in a secure distributed data network. A network where frictionless data exchange is guaranteed, as is each patient's full control over access, utilization, and monetization of their personal health information. Our primary goal is to store and manage patient governance preferences for all your healthcare data. With a simple app, patients can grant access and track usage of their healthcare data. We then make your preferences available to those on your approved list of providers and healthcare entities. There's no need to fill in forms at each provider office. You control who, when and where your healthcare data is used, and for how long. Furthermore you can opt in to temporarily share your de-identified healthcare data with clinical research organizations that offer to pay for its use, reducing your healthcare costs in the process.

Perks

For every $0.15 invested, the Purchaser shall receive 1 PTDIR Token

Key Deal Facts

We'll create a blockchain and IPFS based platform known as PatientDirected.io, that acts as a distributed ledger and secure distributed data store for patient data sharing preferences and agreements.
On this platform, patients can share their personalized healthcare data perferences, as well as make requests for their data to be shared between specific parties. Our public API will allow appropriate and approved parties to access information to assist in the transfer of medical information as directed by the patient. Transfers will be tracked and an immutable audit trail will exist documenting the approved transaction.
Transactions related to de-identified paid information sharing as directed by the patient to clincial research organizations will be effected via smart contracts. This ensures a transparent ledger to allow for market driven pricing, which benefits all parties. It also allow for transparent and efficient payment mechanism to the patient in PDEQ tokens, which are converted to cash immediately unless patients opt-in to store their recieved value as PDEQ crypto tokens.

Use of Proceeds

The use of proceeds of the fund raise is designed to drive PatientDirected towards the completion of its MVP product and attainment of 1M patient members in the next 11 to 18 months. As such there is an emphasis on product development, legal, and business development (G&A) as reflected in our use of proceeds. With respect to R&D product, we need to complete product roadmap and sprint planning using a product manager and a virtual team of web, mobile and blockchain sotware engineers, each used on a consulting basis at rates from $30-$90/hr USD. G & A will cover corporate overhead, including management consulting fees and business development costs related to identifying our first large corporate channel partner. Legal expenses will be related to contract drafting and review for corporate partners and advisors.

Management Team / Advisory Board Bios

Thomas Gianulli MD, MS
President / CEO & Sole Director
Recognized as a healthcare information technology leader and innovator. Recognized CMIO at leading HIT companies.

Deal Notes

  • Non-Voting Common Stock designated as "PDEQ Tokens" and PTDIR Tokens
  • $1.50/share of Non-Voting Common Stock designated as "PDEQ Tokens
  • Minimum Investment Amount (per investor): $399.00
Amount Raised : $6,855
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Non-voting stock is stock that provides the shareholder very little or no vote on corporate matters.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments